3Michalopoulus G K, Zarnegav R. Hepatocyte growth factor. Hepatology, 1992,15 : 149-155.
4Stahl S J,Wingfield P T,Kaufman J D, et al. Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. Biochem J, 1997,326(Pt 3) : 763- 772.
5Danikovitch-Miagkoru A, Zbar B. Dysregulation of Met receptor tyrosion kinase activity in invasion tumors. J Clin Invest, 2002,109: 863 - 867.
6Nakopoulou L, Katsarou S, Giannopoulou I, et al. Correlation of tissue in hibitor of metalloproteinase-2 with proliferative activity and patients survival in breast cancer. Mod Pathol, 2002,15 : 26 - 34.
8Wagatsuma S, Konno R, Sato S, et al. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometril carcinoma. Cancer, 1998, 82 : 520-530.
9Li B, Kanamaru H, Noriki S,et al. Differential expression of hepatocyte growth factor in papillary and nodular tumors of the bladder. Int J Urol, 1998, 5:436 -440.
10Horiguchi N, Takayama H, Toyodal M, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene, 2002,21:1791 - 1799.
2Jahroudi N, Joel S. The role of endothelial cells in tumor invasion and metastasis [J]. J NeuroOncol, 1995, 23: 99-108.
3Nakopoulou L, Katsarou S. Giannopoulou I, et al. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients survival in breast cancer[J]. Mod Pathol,2002, 15: 26-34.
1Daveau M, Scotte M, Francois A, et al. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma[J]. Mol Carcinog, 2003, 36(3) : 130-141.
2Inoue K, Perrotte P, Wood C, Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor[J]. Clin Cancer Res, 2000, 6(11):4422-4431.
3Zeitels S M, Blitzer A, Hillman R E, et al. Foresight in laryngology and laryngeal surgery: a 2020 vision[J]. Ann Otol Rhinol Laryngol Suppl, 2007, 198(9):2-16.
4Hinerman R W, Morris C G, Amdur R J, et al. Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx[J]. Clin Oncol, 2006, 29(6) :613-621.
5Takahashi M, Massui A, Inao M, et al. ERK/MAPK-dependent PI3K/AKt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells[J]. Hepatol Res, 2003, 26(3) :232-236.
6Folkman J. Role of angiogenesis in tumor growth and metastasis [J]. Sem Oncol, 2002, 29(6):15-18.
